Catalent Pharma Solutions, Inc. announced today the appointment of Matthew M. Walsh as Senior Vice President, Finance and Chief Financial Officer, effective April 7, 2008. David A. Eatwell, the incumbent in this role, will be leaving Catalent effective April 4, 2008 to pursue other opportunities.<br /><br />Matthew Walsh, 41, brings to Catalent extensive public company financial leadership experience, most recently as President and Chief Financial Officer of Escala Group, Inc., a global collectibles network and precious metals trader. From 1996 through 2006, Mr. Walsh held positions of increasing responsibility in corporate development, accounting and finance at diversified industrial manufacturer GenTek, Inc., culminating in his appointment as Vice President and Chief Financial Officer. Prior to GenTek, he served in corporate development and other roles in banking and the chemicals industry. Mr. Walsh received a Bachelor of Science degree in chemical engineering and a Master of Business Administration degree from Cornell University, and is a CFA® charterholder.<br /><br />John Lowry, President and Chief Executive Officer of Catalent, said, “I am pleased to welcome Matt as the newest member of our Catalent executive team. His unique combination of experience across operational, treasury and financial disciplines, combined with his public company experience, will enable him to contribute significantly to our success.” Mr. Lowry added, “I would also like to recognize David Eatwell’s important contributions to Catalent over his career, and wish David success in his future endeavors.”